ALEX vs NXRT

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full distress risk assessment. Despite strong historical price performance and a high dividend yield, the company faces significant headwinds with declining revenue and earnings, poor liquidity ratios, and negative insider sentiment. Valuation metrics appear stretched relative to fundamentals, particularly with a forward P/E of 34.02 amid negative growth. The stock trades above both the Graham Number ($17.77) and intrinsic value estimate ($7.07), suggesting overvaluation absent a turnaround.

NXRT exhibits severe fundamental distress, highlighted by a critical Piotroski F-Score of 1/9, indicating profound weakness in financial health. The company is burdened by extreme leverage with a Debt/Equity ratio of 5.65, far exceeding the sector average of 2.38. Most alarming is the dividend payout ratio of 4743.15%, which is mathematically unsustainable and suggests the dividend is being funded by debt or capital reserves rather than earnings. Despite a recent short-term price recovery, the long-term trend is negative with stagnant revenue growth (0.50%) and consistent negative net profit margins.